Metastatic Squamous Neck Cancer With Occult Primary
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Health professional
Treatment of Untreated Metastatic Squamous Neck Cancer With Occult Primary
Source updated: May 14, 2025. Captured 2026-09-09.
Patients with untreated metastatic squamous neck cancer with occult primary have had no previous treatment except supportive care. Patients with neck nodes from a presumed unknown primary tumor should be evaluated as follows:
Surgical biopsy or excision to establish a histological diagnosis, but only after an aerodigestive tract primary has been carefully ruled out by the following procedures:
Surgical biopsy or excision to establish a histological diagnosis, but only after an aerodigestive tract primary has been carefully ruled out by the following procedures:
Direct nasopharyngoscopy, laryngoscopy, bronchoscopy, and esophagoscopy, with biopsy of any suspicious area.
Surgical biopsy or excision to establish a histological diagnosis, but only after an aerodigestive tract primary has been carefully ruled out by the following procedures: › Direct nasopharyngoscopy, laryngoscopy, bronchoscopy, and esophagoscopy, with biopsy of any suspicious area.
If no suspicious lesions are found, random biopsies of the nasopharynx, base of tongue, tonsil, and pyriform sinus on the side of the lesion should be performed.
If the tonsil is not present, biopsy of the tonsillar fossa should be performed.
Sinus x-rays are probably indicated; if an abnormality is found, it should be biopsied as well.
Selected other studies if indicated. Magnetic resonance imaging offers an advantage over computed tomography scans to detect head and neck tumors and to distinguish lymph nodes from blood vessels. It should be considered in the initial evaluation of the patient with metastatic squamous cell cancer in cervical lymph nodes.[1] Positron emission tomography may help determine the primary site.[2]Patients should undergo a full course of radiation therapy or adequate neck dissection, when possible. In cases of fixed massive homolateral adenopathy or bilateral nodes, radiation therapy should be administered first. The radiation fields should also include the nasopharynx, base of tongue, and pyriform sinuses. If radiation therapy is the primary mode of treatment and the neck mass persists upon completion of radiation therapy, cervical lymph node dissection should be performed. Patients with metastatic carcinoma in the supraclavicular region are best managed with a full course of radiation therapy, followed by surgical dissection if palpable tumor persists. Careful continued follow-up of these patients is of utmost importance. Depending on the likely site of origin and histology, chemotherapy appropriate to the most treatable site may be indicated. Accumulating evidence has demonstrated a high incidence (>30%–40%) of hypothyroidism in patients who receive external-beam radiation therapy to the entire thyroid gland or the pituitary gland. Thyroid function testing of patients should be considered before therapy and as part of posttreatment follow-up.[3,4]
Treatment options for untreated metastatic squamous neck cancer with occult primary include:
Radical neck dissection.
Radiation therapy.[5,6] Intensity-modulated radiation therapy may have less short- and long-term toxicity than conventional radiation therapy in terms of xerostomia, acute dysphagia, and skin fibrosis.[7,8]
Source updated: May 14, 2025. Captured 2026-09-09.
The prognosis for most treated patients with progressing, recurring, or relapsing cancer is poor, regardless of cell type or stage. Deciding on further treatment depends on many factors, including the specific cancer, previous treatment, site of recurrence, and individual patient considerations. Treatments that are under clinical evaluation are appropriate and should be considered when possible.
For patients · General Information About Metastatic Squamous Neck Cancer with Occult Primary
Certain factors affect prognosis (chance of recovery) and treatment options.
Source updated: March 14, 2025. Captured 2026-09-09.
Different types of treatment are available for patients with metastatic squamous neck cancer with occult primary. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Radical neck dissection: Surgery to remove tissues in one or both sides of the neck between the jawbone and the collarbone, including:The patient may need physical therapy of the throat, neck, shoulder, and/or arm after radical neck dissection. Radical neck dissection may be used when cancer has spread widely in the neck.
Radical neck dissection: Surgery to remove tissues in one or both sides of the neck between the jawbone and the collarbone, including:The patient may need physical therapy of the throat, neck, shoulder, and/or arm after radical neck dissection. Radical neck dissection may be used when cancer has spread widely in the neck.
Modified radical neck dissection: Surgery to remove all the lymph nodes in one or both sides of the neck without removing the neck muscles. The nerves and/or the jugular vein may be removed.
Partial neck dissection: Surgery to remove some of the lymph nodes in the neck. This is also called selective neck dissection.
After the doctor removes all the cancer that can be seen at the time of surgery, some patients may be given radiation therapy after surgery to kill any cancer cells that are left. Treatment given after surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.
Source updated: March 14, 2025. Captured 2026-09-09.
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer. Intensity-modulated radiation therapy (IMRT) is a type of 3-dimensional (3-D) external radiation therapy that uses a computer to make pictures of the size and shape of the tumor. Thin beams of radiation of different intensities (strengths) are aimed at the tumor from many angles. This type of radiation therapy is less likely to cause dry mouth, trouble swallowing, and damage to the skin.
Radiation therapy to the neck may change the way the thyroid gland works. Blood tests may be done to check the thyroid hormone level in the body before treatment and at regular checkups after treatment.
Source updated: March 14, 2025. Captured 2026-09-09.
This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.
Source updated: March 14, 2025. Captured 2026-09-09.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy).
Source updated: March 14, 2025. Captured 2026-09-09.
Hyperfractionated radiation therapy is a type of external radiation treatment in which a smaller than usual total daily dose of radiation is divided into two doses and the treatments are given twice a day. Hyperfractionated radiation therapy is given over the same period of time (days or weeks) as standard radiation therapy.
Source updated: March 14, 2025. Captured 2026-09-09.
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
For patients · Treatment Option Overview
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Source updated: March 14, 2025. Captured 2026-09-09.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s clinical trials search webpage. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.
Source updated: March 14, 2025. Captured 2026-09-09.
As you go through treatment, you will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back).
For patients
Treatment of Untreated Metastatic Squamous Neck Cancer with Occult Primary
Source updated: March 14, 2025. Captured 2026-09-09.
Patients with untreated metastatic squamous neck cancer with occult primary have not been treated, except to relieve signs and symptoms caused by the cancer. For information about the treatments listed below, visit the Treatment Option Overview section.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
NCT01044433 · COMPLETED · phase2
Head and Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent...